| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/22/2006 | EP1626732A2 Means for preventing and treating cellular death and their biological applications |
| 02/22/2006 | EP1626696A2 Novel fibroblast growth factors and methods of use thereof |
| 02/22/2006 | EP1626694A2 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 02/22/2006 | EP1585985A4 Human pellino polypeptides |
| 02/22/2006 | EP1537211A4 Isolated cytokine receptor licr-2 |
| 02/22/2006 | EP1523491A4 Maize clavata3-like polynucleotide sequences and methods of use |
| 02/22/2006 | EP1463516A4 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 02/22/2006 | EP1451368A4 Single nucleotide polymorphisms in gh-1 |
| 02/22/2006 | EP1427807A4 Estrogen receptor alpha variants and methods of detection thereof |
| 02/22/2006 | EP1296706B1 Osteoclast secreted chemokine and uses thereof |
| 02/22/2006 | EP1244805B1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0932682B1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP |
| 02/22/2006 | EP0656060B1 Androgen regulation with dna sequences of rat probasin gene |
| 02/22/2006 | EP0649537B2 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 02/22/2006 | CN1739029A Prion protein ligands and methods of use |
| 02/22/2006 | CN1738903A Immunization of fish with plant-expressed recombinant proteins |
| 02/22/2006 | CN1738901A Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
| 02/22/2006 | CN1738900A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/22/2006 | CN1738897A Genetic constructs and compositions comprising RRE and CTE and uses thereof |
| 02/22/2006 | CN1738896A Composition and method for treating lupus nephritis |
| 02/22/2006 | CN1738835A Process for the purification of TNF-binding proteins using IMAC |
| 02/22/2006 | CN1738834A Hcv 疫苗 Hcv vaccine |
| 02/22/2006 | CN1738833A Hcv疫苗 Hcv vaccine |
| 02/22/2006 | CN1738832A Ligands |
| 02/22/2006 | CN1738831A Process for designing inhibitors of influenza virus non-structural protein 1 |
| 02/22/2006 | CN1738652A Improved linkers for pharmaceutical compounds |
| 02/22/2006 | CN1738644A Gastrin compositions and methods of use and preparation |
| 02/22/2006 | CN1738643A Composition and method for preventing or treating a virus infection |
| 02/22/2006 | CN1737147A Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein ú¿HSP65-HBcAgú® |
| 02/22/2006 | CN1737144A Composite multiple epitope bivalent nucleic acid vaccine construction for foot-and-mouth disease |
| 02/22/2006 | CN1737143A Rice disease-resistant related gene OsDR2 |
| 02/22/2006 | CN1737142A Rice disease-resistant related gene OsDR3 |
| 02/22/2006 | CN1737141A Landrace fatness candidate gene SOCS-3 sequence and its uses |
| 02/22/2006 | CN1737139A Prostate disease related gene and its coding polypeptide and its uses |
| 02/22/2006 | CN1737138A Pig ouclar muscles area character-related protein and its coding gene and uses |
| 02/22/2006 | CN1737136A Production method of animal use recombinant interferon |
| 02/22/2006 | CN1737121A Escherichia bacteria capable of generating l-amino acid and method for generating l-amino acid |
| 02/22/2006 | CN1737120A Escherichia bacteria capable of generating L-amino acid and method for generating L-amino acid |
| 02/22/2006 | CN1737119A Escherichia bacteria capable of generating l-amino acid and method for generating l-amino acid |
| 02/22/2006 | CN1737010A Galactose albumin preparation method |
| 02/22/2006 | CN1243097C Human ICAM-1 extramembranous I-III domain gene expression product ,its prep. and application in radioimmunological technology |
| 02/22/2006 | CN1243095C Extracting process of actinidia proteinase |
| 02/22/2006 | CN1243022C Biologically modified and recombinant human growth hormone compound and preparing method thereof |
| 02/22/2006 | CN1243021C Interleukin-18 binding proteins, their preparation and use |
| 02/22/2006 | CN1243020C Application of cardiokinetic hormone in liver disease |
| 02/22/2006 | CN1243019C Separation and purification process of recombinant human erythrogenin |
| 02/22/2006 | CN1243018C Blood vessel generating inhibitor |
| 02/22/2006 | CN1243017C Tumor suppressor, coded protein and application thereof |
| 02/22/2006 | CN1243016C Beta tubulin of cotton fiber and its coding gene and application |
| 02/22/2006 | CN1243015C Separating and purifying technology for micro algae phycoerythrin |
| 02/22/2006 | CN1242809C Applications of T-BAM (CD40L) technology in preparation of medicine to treat diseases involving smooth muscle cell |
| 02/21/2006 | US7002064 Inbred corn line A60059 |
| 02/21/2006 | US7002059 introducing novel expansin gene sequences from heterologous and homologous tree species into Eucalyptus trees so as to alter expansin levels; modification of morphology of plant fibre cells; for use in paper |
| 02/21/2006 | US7002057 Thioredoxin H homologs |
| 02/21/2006 | US7002002 Vaccine against an infectious pathogen from Mycobacterium; 110-12 kd extracellular product proteins |
| 02/21/2006 | US7002001 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection |
| 02/21/2006 | US7002000 Nucleic acid encoding α chain of human IL-11 receptor |
| 02/21/2006 | US7001995 Synthetic human papillomavirus genes |
| 02/21/2006 | US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin |
| 02/21/2006 | US7001992 Antibodies to secreted protein HEMCM42 |
| 02/21/2006 | US7001991 transferrin-doxorubicin linked with glutaraldehyde; low-toxicity, side-effect reduction |
| 02/21/2006 | US7001990 Canola protein isolate functionality II |
| 02/21/2006 | US7001989 Conjugates comprising two active agents |
| 02/21/2006 | US7001988 Wound healing agents |
| 02/21/2006 | US7001987 Hydrogel with controllable mechanical, chemical, and biological properties and method for making same |
| 02/21/2006 | US7001986 Fluorescent proteins |
| 02/21/2006 | US7001985 for controlling activity of cyclin-dependent kinases; treating cancer, immune disorders |
| 02/21/2006 | US7001983 Non-hemolytic cytolytic peptides;antibacterial, anticancer, antiprotozoal agents |
| 02/21/2006 | US7001891 Biodegradable polycation composition for delivery of an anionic macromolecule |
| 02/21/2006 | US7001890 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 02/21/2006 | US7001885 Isolation of biopolymers from human serum albumin; obtain human serum albumin, expose to ion exchange resin, elute and recover biopolymer |
| 02/21/2006 | US7001884 polypeptide with selective amino acid substitutions; nontoxic protease inhibitors; bactericides, fungicides, viricides |
| 02/21/2006 | US7001883 Cyclized conotoxin peptides |
| 02/21/2006 | US7001882 Muteins of bilin-binding protein |
| 02/21/2006 | US7001881 joint-lubricating glycoproteins; polypeptide and O-linked oligosaccharide moiety [B(1-3)Gal-GalNAc]; antiarthritic agent maintains viscosity of synovial fluid; osteoarthritis |
| 02/21/2006 | US7001769 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 02/21/2006 | US7001768 Targeted modification of chromatin structure |
| 02/21/2006 | US7001767 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies |
| 02/21/2006 | US7001766 Nucleotide sequences coding polypeptide for use the treatment of hypercholesterolaemia, diabetes, hypercholesterolaemia, hypoglycemia, graves disease, goiter, cushing's, addison, gastrointestinal and autoimmune diseases |
| 02/21/2006 | US7001764 Compositions comprising tissue specific adenoviral vectors |
| 02/21/2006 | US7001762 Neurospora crassa (N. crassa); nucleotide sequences; vectors and host cells; silencing gene has a RNA-dependent RNA polymerase domain; use to study gene silencing as it pertains to expression of transgenes |
| 02/21/2006 | US7001761 DNA sequences comprising dystrophin minigenes and methods of use thereof |
| 02/21/2006 | US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects |
| 02/21/2006 | US7001743 Nucleotide sequences coding polypeptide for use in controlling cell enlargement in plants |
| 02/21/2006 | US7001742 Human uncoupling protein 3 |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001733 Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
| 02/21/2006 | US7001732 RIP3 associated cell cycle protein |
| 02/21/2006 | US7001731 Antibody specific for a chemokine receptor; immunoassay and kits |
| 02/21/2006 | US7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 02/21/2006 | US7001728 Protein of given amino acid sequence which is the product of a gene which shows enhanced expression due to stimulation with TNF alpha; use drug screening; plays an important role in protein protein interactions; drug target |
| 02/21/2006 | US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/21/2006 | US7001598 Administering lymphotoxin beta receptor-alpha/beta heteromeric complex and a pharmaceutically acceptable carrier for therapy or reducing the advancement, severity or effects of neoplasia |
| 02/21/2006 | US7001597 Methods for altering fertility |